Platforms and biological resources
ICI research centres have installed the following state-of-the-art infrastructure:
- proteomics(IBiSA)
- immunomonitoring (IBiSA),
- nanobodies (IBiSA),
- biobanking (IBiSA),
- bioinformatics,
- oncogenomics,
- microarray and next generation sequencing (IBiSA),
- confocal and advanced dynamic microscopy (IBiSA Imaglmm, confocal, two-photon and super-resolution microscopy, transmission tomography and scanning electron microscopy)
- flow cytometry and cell sorting,
- cell analysis,
- functional genomics(C. elegans),
- experimental histo-pathology, computer datacenter and scientific computing,
- data management and analysis centre,
- coordinated network of A2/A3 animal houses.
In addition to the IBiSA platforms and the platforms of Aix Marseille University (AMU), certain infrastructures and biological resources related to oncology and immunology have been recognized as national priorities:
- Immunophenomics Center(CIPHE supported by Equipex Phenomix, PIA1) dedicated to the generation of mouse models,
- MI-mABS (supported by Demonstrator, PIA2) for the development of therapeutic antibodies,
- CryoStem (supported by Cohortes, PIA2) for research in hematopoietic stem cell transplantation,
- Marseille Clinical Investigation Center ,
- two early-phase clinical trial centers in oncology(CLIP²) at thePaoli-Calmettes Institute and theMarseille Public Hospitals, accredited by theNational Cancer Institute.
Contact information
email: ici-contact@univ-amu.fr
Keywords
Institute for Cancer and Immunology, HERE
cancer, cancer, immunology, immuno
platforms, resources